Insulet
PODD
#2016
Rank
S$12.29 B
Marketcap
S$177.19
Share price
-1.96%
Change (1 day)
-60.83%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

EPS for Insulet (PODD)

EPS in 2026 (TTM): S$7.64

According to Insulet's latest financial reports the company's current EPS (TTM) is S$7.67. In 2024 the company made an earnings per share (EPS) of S$7.72 an increase over its 2023 EPS that were of S$3.81.

EPS history for Insulet from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$7.64
2024S$7.72102.71%
2023S$3.814114.29%
2022S$0.09038-69.57%
2021S$0.30109.09%
2020S$0.14-38.89%
2019S$0.23200%
2018S$0.07747-113.04%
2017S-$0.59-9.8%
2016S-$0.66-60.47%
2015S-$1.6738.71%
2014S-$1.2012.05%
2013S-$1.07-23.15%
2012S-$1.39-12.2%
2011S-$1.59

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$8.62 12.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$3.49-54.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
S$5.27-31.31%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
S$39.89 420.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
S-$1.20-115.66%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
S$1.55-79.80%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
S$3.34-56.40%๐Ÿ‡บ๐Ÿ‡ธ USA